Delivery Order SPE2DB20D1051-SPE2DB25FD6RD
Award Date
1/14/25
Potential Completion Date
1/15/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Exforge 5-160 mg tablets. The contract, valued at $1,323.76, has a firm fixed price pricing type and an ultimate completion date of August 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $15,834.87, is a Delivery Order contract for Exforge 10-320 mg tablets. The contract has an ultimate completion date of October 31, 2024 and a firm fixed price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Exforge 5-160 mg tablets. The contract has a ceiling value of $4,172.08 and a completion date of January 23, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Exforge 5-320 mg tablets. The contract has a ceiling value of $2,186.96 and runs through January 16, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a key vendor for federal healthcare programs, particularly within...
This federal contract award, valued at $5,560.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Exforge 5-160 mg tablets, a medication used to treat high blood pressure. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,133.10, is a Firm Fixed Price Delivery Order for the supply of EXFORGE 5-160 MG TABLET 30S. The contract has an ultimate completion date of January 14, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This federal contract award, with the ID SPE2DB20D2104|SPE2DB25FMELL, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566759953 Exforge 5-160 mg tablet 30s, with a firm fixed price of $1,835.55 and a completion date of December 19, 2024. The contract is a delivery order type, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor,...
This federal contract award, with ID SPE2DB24D2101|SPE2DB24FKGQM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Exforge 5-160 mg tablet in 30-count packages. The contract has a total ceiling value of $4,466.29 and is a Firm Fixed Price delivery order, with a final completion date of September 19, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award, which does not have a set-aside...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order under an Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corporation's Corporate Office division. The $3,221.03 firm fixed price contract is for the delivery of Exforge 5-160 mg tablets, a prescription medication. The award is not set aside and is part of Amerisourcebergen's broader IDC with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Exforge 10-320 mg tablets in support of the Medical Supply Chain program at the Defense Logistics Agency (DLA). The contract has a ceiling value of $11,592.55 and an ultimate completion date of May 19, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc.,...